FDA Issues Guidance On IDEs For Knee Cartilage Replacement
Investigational device exemption (IDE) applications for knee cartilage replacement products should include a detailed product description, manufacturing and packaging methodology, and nonclinical testing data to assess biological responses and toxicology, FDA advises in a July 9 1draft guidance
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
